Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Gershlick

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Hospital Medicine (London, England : 1998)|November 2, 2001
Keeping the coronary arteries open: current opportunitiesA H Gershlick
European Heart Journal|May 1, 1997
Treating the non-electrical risks of atrial fibrillationA H Gershlick
European Heart Journal|September 24, 1999
Blood markers of cardiovascular diseaseA H Gershlick
Hospital Medicine (London, England : 1998)|March 29, 2000
Antiplatelet therapyA H Gershlick
Heart (British Cardiac Society)|January 10, 1998
Antiplatelet therapy following stent deploymentA H Gershlick
Atherosclerosis|February 19, 2002
Treating atherosclerosis: local drug delivery from laboratory studies to clinical trialsA H Gershlick
Clinical Medicine (London, England)|May 16, 2008
Contemporary percutaneous coronary intervention--30 years in the makingA H Gershlick
European Heart Journal|February 1, 1994
Principles of platelet inhibitor therapy--where we stood in 1993A H Gershlick
European Heart Journal|January 17, 2002
Acute coronary syndromes: optimizing the therapeutic optionsA H Gershlick
British Heart Journal|June 1, 1994
Is this the end of the aspirin and vein graft story?A H Gershlick
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Hospital Medicine (London, England : 1998)|November 2, 2001
Keeping the coronary arteries open: current opportunitiesA H Gershlick
European Heart Journal|May 1, 1997
Treating the non-electrical risks of atrial fibrillationA H Gershlick
European Heart Journal|September 24, 1999
Blood markers of cardiovascular diseaseA H Gershlick
Hospital Medicine (London, England : 1998)|March 29, 2000
Antiplatelet therapyA H Gershlick
Heart (British Cardiac Society)|January 10, 1998
Antiplatelet therapy following stent deploymentA H Gershlick
Atherosclerosis|February 19, 2002
Treating atherosclerosis: local drug delivery from laboratory studies to clinical trialsA H Gershlick
Clinical Medicine (London, England)|May 16, 2008
Contemporary percutaneous coronary intervention--30 years in the makingA H Gershlick
European Heart Journal|February 1, 1994
Principles of platelet inhibitor therapy--where we stood in 1993A H Gershlick
European Heart Journal|January 17, 2002
Acute coronary syndromes: optimizing the therapeutic optionsA H Gershlick
British Heart Journal|June 1, 1994
Is this the end of the aspirin and vein graft story?A H Gershlick
Pageof 8